The head of France's largest supermarket chain, E. Leclerc, announced that the company would continue selling Pepsi products after rival Carrefour decided to remove PepsiCo items from their shelves. This move marks the latest pricing clash between retailers and global food giants.
Reuters reported that Michel Edouard Leclerc expressed optimism regarding food inflation in France, expecting it to return to a range of 2.5% to 3% this year.
Persistence in Negotiations
Leclerc addressed the ongoing price negotiations with suppliers, which are set to conclude on January 31, as per Market Screener. He revealed that he had requested price reductions from French food giant Danone, aiming for them to take effect in February-March. Noting that decisions for the year are currently being made, Leclerc emphasized the importance of seeking advantageous terms for consumers.
As Leclerc stated his ambition to be the most affordable retailer in France, he expressed his intention to approach Danone regarding deflation, albeit without specifying a figure. With a focus on providing high-quality products at reasonable prices, Leclerc aimed to demonstrate that lower prices could increase suppliers' revenue.
France's Pricing Debate
The debate over staple prices has permeated France, with retailers arguing that price increases imposed by producers are unwarranted. In response, the government has mandated an earlier conclusion to annual price negotiations between retailers and suppliers, seeking to mitigate inflation.
When asked if E. Leclerc would follow Carrefour's lead and remove Pepsico or other products due to high prices, Leclerc responded, "I continue to sell Pepsi." He remained confident that emphasizing the potential for increased revenue with lower prices would prove more compelling than a display of strength.
Last week, Carrefour announced that its stores in France, Belgium, Italy, Spain, and Poland would no longer stock Pepsi, Lay's Crisps, Cheetos, and 7up due to what it referred to as "unacceptable price hikes."
Photo: Olena Bohovyk/Unsplash


HUTCHMED, AstraZeneca Seek FDA Approval for Lung Cancer Combo
CSL Partners With AWS to Bring AI Into Drug Research
BlackRock Sees AI Agents Fueling New Crypto Demand
Apple CEO John Ternus Plans Major Overhaul
Cboe Extends SPX Options Deal, Eyes Tokenized Contracts
Robinhood Launches AI Agents for Automated Trading
Hengrui Shares Rise on $2.6 Billion Novo Nordisk Obesity Drug Deal
CNN, Politico and MS NOW Seek Court Order Blocking Trump White House Ban
Toyota Global Sales Fall for Seventh Month as China Demand Slumps
Pepco Raises FY26 Earnings Outlook, Unveils €400 Million Buyback
Goldman Sachs Private Credit Fund Sees Redemptions Ease in Q3
Grayscale Sees Zcash Gaining Market Share Against Bitcoin
Aztec Revives zk.money for Private Ethereum Payments
DeepSeek, Huawei Partner on Ascend AI Chip Programming Tools
Bitwise Launches NEAR ETF as $562 Bull Case Fuels AI Crypto Buzz
Google Pays Publishers for AI Search Content in New Pilot
Samsung Invests $1 Billion in KKR’s Helix AI Infrastructure 



